Respiratory viral infections in high-risk patients

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 11, 2004, Pages 1142-1143

  Greenberg, Stephen B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; INTERFERON; OSELTAMIVIR; PALIVIZUMAB; PLECONARIL; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ACUTE RESPIRATORY TRACT DISEASE; CORONAVIRUS; DIAGNOSTIC TEST; EDITORIAL; HIGH RISK PATIENT; HUMAN; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MYCOPLASMA PNEUMONIAE; NONHUMAN; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; SIDE EFFECT; VIRUS INFECTION;

ACUTE DISEASE; ANTIVIRAL AGENTS; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 9644258924     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2409002     Document Type: Editorial

References (17)

1. Greenberg SB. Respiratory viral infections in adults. Curr Opin Pulm Med 2002;8:201-208.
2. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N. Yousuf H, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-782.
3. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-50S.
4. Malcom E, Arruda E, Hayden FG, Kaiser L. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol 2001;121:9-16.
5. Garbino J, Gerbase MW, Wunderli W, Kolarova L, Nicod L, Rochat T, Kaiser L. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 2004;125:1033-1039.
6. Beckham JD, Cadena A, Lin J, Piedra PA, Glezen WP, Greenberg SB, Atmar RL. Respiratory viral infections in patients with chronic obstructive pulmonary disease. J Infect (In press)
7. Seemungal TA, Wedzicha JA. Viral infections in obstructive airway diseases. Curr Opin Pulm Med 2003;9:111-116.
8. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:115-120.
9. Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L, et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 2004;170:1197-1203.
10. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:167-173.
11. Atmar RL, Guy E. Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998;158:2453-2459.
12. Marcolini JA, Malik S, Suki D, Whimbey E, Bodey GP. Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis 2003;22:79-84.
13. Kneyber MC, Kimpen JL. Advances in respiratory syncytial virus vaccine development. Curr Opin Investig Drugs 2004;5:163-170.
14. Group TIRS. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.
15. Maggon K, Barik S. New drugs and treatment for respiratory syncytial virus. Rev Med Virol 2004;14:149-168.
16. Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, Patick AK, Smith GJ III, Zalman LS. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003;47:3907-3916.
17. Wat D. The common cold: a review of the literature. Eur J Intern Med 2004;15:79-88.